Tate & Lyle Discloses Year-End ADR Sale by Non-Executive Director

Tate & Lyle ( (GB:TATE) ) has issued an announcement.

Tate & Lyle has disclosed that non-executive director and person discharging managerial responsibilities (PDMR) Glenn Fish sold 5,000 American Depositary Receipts on 17 December 2025 at a price of US$20.11 per ADR on the OTCQX exchange. The company stated the sale was undertaken for year-end portfolio rebalancing and tax alignment, noting that Fish retains 49.8 ADRs and intends to repurchase ADRs early in 2026, a signal aimed at reassuring investors that the transaction does not reflect reduced confidence in the business.

The most recent analyst rating on (GB:TATE) stock is a Hold with a £401.00 price target. To see the full list of analyst forecasts on Tate & Lyle stock, see the GB:TATE Stock Forecast page.

Spark’s Take on GB:TATE Stock

According to Spark, TipRanks’ AI Analyst, GB:TATE is a Neutral.

Tate & Lyle’s overall stock score reflects stable financial performance and positive corporate events, such as insider share purchases. However, technical indicators and valuation suggest caution, with high P/E ratios and neutral momentum. Earnings call insights highlight current market challenges, balancing the positive aspects.

To see Spark’s full report on GB:TATE stock, click here.

More about Tate & Lyle

Tate & Lyle PLC is a global food and beverage ingredients company, best known for producing sweeteners, texturants and other speciality ingredients used by manufacturers worldwide. Its shares are also traded in the US via American Depositary Receipts (ADRs), each representing four ordinary shares in the company.

Average Trading Volume: 2,119,505

Technical Sentiment Signal: Sell

Current Market Cap: £1.65B

For an in-depth examination of TATE stock, go to TipRanks’ Overview page.